Pediatrics

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

Evkeeza, which treats a rare form of high cholesterol, is now approved for patients as young of 5 years.

Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.

With nearly 250,000 kindergarten age children not receiving their recommended vaccines, pediatric health care providers search for solutions.

The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.

The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.

The FDA has granted Priority Review for linclotide (LINZESS; Ironwood Pharmaceuticals) for treating functional constipation in pediatric patients.

The FDA has updated its compounding guidelines for licensed pharmacies, hospitals, and health systems.

Results of a phase 3 clinical trial represent another avenue of treatment for children and adolescents living with type 2 diabetes.

A 2021 morbidity study found that COVID-19 was among the leading causes of death in children and young people.

Odactra, a tablet for treating pediatric house dust mite-induced allergic rhinitis, has been approved by the US Food and Drug Administration for patients aged 12 to 17 years.

A study aims to quantify the burden of current childhood asthma in the United States in association with smoke from indoor gas stoves.

In a report from the Centers for Disease Control and Prevention, it was shown that symptoms and hospitalizations associated with influenza this season are higher among children than adults.

A follow-up of a trial cohort showed that children aged 5 years born to pregnant smokers had improved airway function when vitamin C supplementation was administered during pregnancy compared to placebo.

A recent study found a rise in the prevalence of antipsychotic prescriptions among pediatric patients and noted which antipsychotics were most commonly used for specific indications.

The updates include new recommendations for COVID-19 and pneumococcal vaccines.

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.

Pharmacists can play an important role in patients’ wellness journeys.

Careful thought and adjustments are required to avoid exceeding the maximum recommended amount.

Patients with a history of multisystem inflammatory syndrome in children (MIS-C) completed a questionnaire about adverse reactions following COVID-19 vaccination, and no serious adverse events were recorded.

The US Food Administration has agreed to review an application for nirsevimab (Beyfortus; AstraZeneca and Sanofi) to protect infants against RSV.

The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.

Take a look back at our most popular pediatric coverage for 2022.

The US Food and Drug Administration has updated the emergency use authorization for bivalent COVID-19 vaccines to be available for children aged 6 months and older.

A recent article highlighted multiple forms of treatment for atopic dermatitis, detailing their benefits and adverse events.

Cost savings were not associated with an increase in adverse drug events.

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Shortages are leaving patients in the lurch.

The US was the first country to begin universal vaccination of children against varicella.